DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Merseburger AS, Rüssel C, Belz H. et al.
Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy.
Aktuelle Urol 2020;
DOI: 10.1055/a-1121-7593. [Epub ahead of print]
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.